Communicating the Value of Standards
To me the need for standards in clinical research seems well, quite frankly, obvious but perhaps that comes of working with CDISC for 5 years. In the past few months, I have come to understand that there are many reasons why companies struggle to implement standards and what interests me most, is that it is [...]
Social Media for Clinical Research Data?
Keeping abreast of the rapid developments with social media is not easy, particularly in the highly regulated biopharmaceutical environment. Every week, something new happens that prompts debate and outpourings from various sources. So you can imagine my surprise when considering that social networks were really for marketing purposes, I came across a blog in the [...]
EHRs, Blogs and Thoughts
I have read two interesting Blogs over the last day or so: one pointed me to the latest social media guidance for the pharma industry from the PMCPA which is one step ahead of the FDA Guidance I wrote about last week and the other was looking at the wider use of EHRs and patient [...]
FDA Social Media Guidance: To be or not to be?
It has been interesting to read over the last few weeks that the FDA have delayed their Guidance on Social Media again. Some see it as irresponsible, as habits are already forming in the biopharmaceutical sector, others have described it as walking around with a blindfold on and hoping they won’t hit anything too sharp [...]
4 Comments